Clinical characteristics |  | N = 60 |
---|---|---|
Age in years |  | 56 (47–65) |
Female sex | Â | 37 (62) |
Chronic heart failure | Â | 0 (0) |
Previous myocardial infarction | Â | 3 (5) |
Pre-existing hypertension | Â | 22 (37) |
Smoking history | Â | 24 (40) |
Admission H&H grade | 1 | 3 (5) |
 | 2 | 6 (10) |
 | 3 | 14 (23) |
 | 4 | 6 (10) |
 | 5 | 31 (52) |
GCS at ICU admission |  | 3 (3–10) |
LOC at ictus | Â | 36 (60) |
Admission radiological characteristics | ||
Modified Fisher Scale | 1 | 2 (3) |
 | 2 | 2 (3) |
 | 3 | 13 (22) |
 | 4 | 43 (72) |
ICH present on admission CT scan | Â | 30 (50) |
Hydrocephalus requiring EVD placement | Â | 42 (70) |
Global cerebral edema | Â | 24 (40) |
Aneurysm treatment | ||
Endovascular coiling | Â | 31 (52) |
Neurosurgical clipping | Â | 27 (45) |
Non-aneurysmal SAHa | Â | 2 (3) |
Complications and treatment | ||
Neurogenic myocardial stunning | Â | 23 (38) |
Pneumonia | Â | 42 (70) |
Ventriculitis | Â | 7 (12) |
Vasospasm | Â | 48 (80) |
Delayed cerebral ischemia | Â | 25 (42) |
Noradrenaline, daily dose in mgb |  | 11 (5–25) |
Dobutamine, daily dose in mgb |  | 33 (0–258) |
Phenylephrine, daily dose in mgb |  | 0 (0–3) |
Outcome characteristics | ||
Length of ICU stay in days |  | 28 (18–39) |
In-hospital mortality | Â | 14 (23) |
3-month mRS | 0 | 2 (3) |
 | 1 | 8 (13) |
 | 2 | 6 (10) |
 | 3 | 10 (17) |
 | 4 | 9 (15) |
 | 5 | 10 (17) |
 | 6 | 15 (25) |